post myocardial infarction - antithrombotics - all type of patients clinical trials results meta-analysis

<h1> <a href="index.html"> <strong>post myocardial infarction</strong> - antithrombotics </a> - all type of patients trial results systematic overview and meta-analysis </h1> <h2>Main characteristics of the included studies</h2> <table> <tr> <th>Trial</th> <th>Treatments</th> <th>Patients</th> <th>Methods</th> </tr> <tr> <td> <a href="index.html"> REDEEM, 2009 </a> <br> NCT00621855 </td> <td> dabigatran 4 dosages (50mg twice daily, 75mg twice daily, 110mg twice daily, 150mg twice daily)<br>  <i>versus</i> <br> placebo </td> <td> patients with recent acute coronary syndromes (ST- or non-ST-elevation myocardical infarction) </td> <td> follow-up 6 months<br> n=1501/373<br> Parallel groups<br> double blind <br> </td> </tr> </table> <h2>References</h2>